MEDmin

Inspiration

The idea for MEDmin came from a very ordinary, very frustrating moment: a family member needed an antibiotic at 11 PM, and the nearest 24-hour pharmacy was a 20-minute drive away — while a small chemist shop two streets away almost certainly had it in stock, just not online. We started asking around and realized this wasn't a one-off. Most e-pharmacy apps route every order through a centralized warehouse, even when a local chemist could fulfill it in minutes. For someone managing a fever at midnight, or an elderly parent who's run out of a heart medication, "next-day delivery" isn't good enough.

That gap — between medicine that already exists nearby and medicine that actually reaches you in time — is what MEDmin exists to close. We wanted "minutes" to be an actual service-level promise, not a marketing word, especially for the people who need it most: elderly patients living alone, chronic-illness patients on recurring prescriptions, and caregivers trying to look after a parent from another city.

What It Does

MEDmin is a hyperlocal, on-demand marketplace that connects customers to the nearest verified pharmacy with live stock and dispatches a dedicated rider — medicine delivered in minutes, not hours.

AI-Powered Prescription Reading — the customer photographs a prescription; AI decodes the doctor's handwriting instantly, with manual entry as a fallback whenever the model isn't confident. Emergency SOS Mode — one tap for urgent needs auto-prioritizes the nearest stock and the fastest available rider, skipping standard matching heuristics. Live Tracking & Auto-Refill — real-time GPS delivery tracking, plus automatic subscriptions for chronic and elderly patients so recurring medicines never require manual reordering. Verified Pharmacy Network — every partner pharmacy carries hygiene and authenticity trust badges, so customers know exactly who is fulfilling their order. Zero-Inventory Model — MEDmin holds no stock, no cold storage, and no drug license. It is purely the technology layer matching customers to independently licensed pharmacies — the same legal structure used by leading e-pharmacy players in India today. How We Built It

We designed MEDmin around one core architectural decision: MEDmin owns no inventory. It's a technology layer, which meant our entire build was about matching, verification, and real-time state — not supply chain.

Order flow:

$$\text{Customer} \xrightarrow{\text{photo/search}} \text{AI OCR} \xrightarrow{\text{match}} \text{Nearest Pharmacy (live stock)} \xrightarrow{\text{dispatch}} \text{Rider} \xrightarrow{\text{GPS}} \text{Delivery}$$

Stack:

Client apps: React Native, with three distinct experiences — customer, delivery rider, and partner pharmacy — sharing a common backend but very different UX needs. Backend: Node.js with PostgreSQL, chosen for straightforward relational modeling of orders, pharmacy stock, and verification states. Live tracking: Google Maps API for real-time rider location. Prescription reading: a custom OCR + handwriting-recognition pipeline trained on prescription-style data, gated by a confidence threshold — below it, the system asks the customer to type the medicine name instead of guessing.

The piece we cared about most was the double-verification loop: every prescription passes AI pre-screening first, but a licensed pharmacist always gives manual sign-off before dispatch. The AI is a speed layer, never an approval authority.

Challenges We Ran Into Handwriting recognition on real-world prescriptions. A model that's "pretty good" is dangerous in a medical context — a misread drug name is not an acceptable failure mode. We had to design for graceful degradation (falling back to manual entry) rather than chasing marginal accuracy gains. Balancing speed with safety. Every feature that made delivery faster — auto-prioritization, live stock matching, one-tap SOS — had to be weighed against never skipping pharmacist verification. Most of our design debates were really about where to draw that line. Designing for a regulatory gray zone. India's e-pharmacy rules are still evolving, so we had to build a product whose architecture itself is the compliance strategy — structuring MEDmin strictly as a marketplace intermediary under the IT Act, 2000, rather than bolting on compliance after the fact. Cold-chain medicines. Insulin, vaccines, and other temperature-sensitive drugs don't fit neatly into an "any nearby rider" delivery model, pushing us toward insulated transport and rider training as a distinct delivery class. Two-sided marketplace cold start. MEDmin only works if pharmacy supply and customer demand both exist in a given area from day one — which pushed us toward a hyperlocal, neighborhood-by-neighborhood rollout strategy instead of a broad simultaneous launch. Accomplishments That We're Proud Of Designing a zero-inventory architecture that is simultaneously the fastest path to market and the cleanest legal position — a rare case where the pragmatic engineering choice and the regulatory-safe choice turned out to be the same choice. Building a double-verification system where AI accelerates the pharmacist rather than replacing them, so speed never comes at the cost of a licensed human check on every single prescription. Designing Emergency SOS mode as a genuinely different code path optimized purely for time-to-delivery, not just a re-skinned version of a normal order. Grounding the entire business case in real market and legal research — India's online pharmacy market growing from roughly $3.71B (2025) to $14.08B (2034) at a ~16% CAGR — rather than treating market sizing as an afterthought slide. Landing on a product that speaks directly to an emotionally real problem: elderly and chronic-illness patients living alone being able to get medicine in minutes, and families being able to check in on a parent's deliveries from anywhere. What We Learned "AI-powered" is easy to say and hard to earn. For anything touching a prescription, AI confidence has to be a first-class product signal, not an implementation detail. Healthcare regulation is core product design, not a footnote. Reading through the Drugs & Cosmetics Act, 1940 and e-pharmacy draft rules directly shaped our architecture — the difference between an inventory model and a marketplace model isn't a legal technicality, it's the difference between a viable business and a regulatory nightmare. Trust is the actual product. Riders, pharmacies, prescriptions, and delivery windows all touch someone's health — so verification and transparency mattered more to our design decisions than almost any pure speed optimization. What's Next for MEDmin Pilot launch in a single dense neighborhood to validate the two-sided marketplace loop before expanding city-wide. Expanding the verified pharmacy network with a formal onboarding and audit process for hygiene and authenticity badges. Improving OCR accuracy with a larger, more diverse prescription dataset, and tighter feedback loops from pharmacist corrections back into the model. Cold-chain delivery tier — dedicated insulated-bag riders and SLAs specifically for insulin, vaccines, and other temperature-sensitive medicines. Deeper caregiver tools — shared family accounts, medication adherence reminders, and multi-patient dashboards for caregivers managing medicines for more than one family member. Regulatory engagement — working proactively with local health authorities as India's e-pharmacy rules continue to formalize, to ensure MEDmin's marketplace model stays ahead of compliance requirements rather than reacting to them.